Skip Ribbon Commands
Skip to main content
Menu

Publications

Selected publications:

  1. Chua ML, Wee JT, Hui EP, Chan AT. Nasopharyngeal Carcinoma. Lancet. 2016 Mar 5. 387(10022):1012-24.
  2. Glynne-Jones R, Tan D, Hughes R, Hoskin P. Squamous-cell carcinoma of the anus: progress in radiotherapy treatment. Nat Rev Clin Oncol. 2016 Jul;13(7):447-59.
  3. Chua ML, Bristow RG. Testosterone in Androgen Receptor Signaling and DNA Repair: Enemy or ‘Frenemy’? Clin Cancer Res 2016 Jul 1;22(13):3124-6.
  4. Chua ML, Chan AT. Gemcitabine: a game changer in nasopharyngeal carcinoma. Lancet. 2016 Oct 15;388(10054):1853-1854.
  5. Nuta O, Somaiah N, Boyle S, Chua ML, Gothard L, Yarnold J, Rothkamm K, Herskind C. Erratum to "Correlation between the radiation responses of fibroblasts cultured from individual patients and the risk of late reaction after breast radiotherapy" Cancer Lett. 2016 Aug 1;378(1):68.
  6. Luo J, Zhou Z, Yang Z, Chen X, Cheng J, Shao Z, Guo X, Tuan J, Fu X, Yu X. The Value of 18F-FDG PET/CT Imaging Combined With Pretherapeutic Ki67 for Early Prediction of Pathologic Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer. Medicine (Baltimore). 2016 Feb;95(8):e2914.
  7. Nuta O, Somaiah N, Boyle S, Chua ML, et al. Correlation between the radiation responses of fibroblasts cultured from individual patients and the risk of late reaction after breast radiotherapy. Cancer Lett 2016 May 1;374:324-30.
  8. Mörseburg A, Pagani L, Ricaut FX, Yngvadottir B, Harney E, Castillo C, Hoogervorst T, Antao T, Kusuma P, Brucato N, Cardona A, Pierron D, Letellier T, Wee J, Abdullah S, Metspalu M, Kivisild T. Multi-layered population structure in Island Southeast Asians. Eur J Hum Genet. 2016 Nov;24(11):1605-1611.
  9. Somaiah N, Chua ML, Bourne S, et al. Correlation between DNA damage responses of skin to a test dose of radiation and late adverse effects of earlier breast radiotherapy. Radiother Oncol 2016 May; 119(2):244-9.
  10. Szyszko T, Yip C, Szlosarek P, Goh V, Cook GJR. The role of new PET tracers for lung cancer. Lung Cancer 2016 Apr;94:7-14.
  11. Kusumawidjaja G, Gan PZ, Ong WS, Teyateeti A, Dankulchai P, Tan DY, Chua ET, Chua KL, Tham CK, Wong FY, Chua ML. Dose-escalated intensity-modulated radiotherapy and irradiation of subventricular zones in relation to tumor control outcomes of patients with glioblastoma multiforme. Onco Targets Ther. 2016 Mar 2;9:1115-22.
  12. Sommat K, Yit NL, Kwok LL. Comparison between 4-MV and 6-MV radiotherapy in T1N0 glottic cancer. Laryngoscope. 2016 May 30. [Epub ahead of print]
  13. Wang HY, Chang YL, To KF, Hwang JS, Mai HQ, Feng YF, Chang ET, Wang CP, Kam MK, Cheah SL, Lee M, Gao L, Zhang HZ, He JH, Jiang H, Ma PQ, Zhu XD, Zeng L, Chen CY, Chen G, Huang MY, Fu S, Shao Q, Han AJ, Li HG, Shao CK, Huang PY, Qian CN, Lu TX, Li JT, Ye W, Ernberg I, Ng HK, Wee JT, Zeng YX, Adami HO, Chan AT, Shao JY. A new prognostic histopathologic classification of nasopharyngeal carcinoma. Chin J Cancer. 2016 May 5;35(1):41.
  14. Yip C, Cook GJR, Landau DB, Davies A, Goh V. The performance of different imaging modalities in assessment of response to neoadjuvant therapy in primary esophageal cancer. Dis Esop 2016 Feb:29(2):116-130.
  15. Wee JT, Soong YL, Poh SS, Chua ML. Nasopharyngeal carcinoma-some closing remarks. Chin Clin Oncol. 2016 Apr;5(2):29.
  16. Yip C, Cook GJ, Wee J, Fong KW, Tan T, Goh V. Clinical significance of hypoxia in nasopharyngeal carcinoma with a focus on existing and novel hypoxia molecular imaging. Chin Clin Oncol. 2016 Apr;5(2):24.
  17. Wee JT, Soong YL, Chua ML. Nasopharyngeal carcinoma-past lessons and a glimpse into the future. Chin Clin Oncol. 2016 Apr;5(2):14.
  18. Pierce K. H. Chow, Su Pin Choo, David C. E. Ng, Richard H. G. Lo, Michael L. C. Wang, Han Chong Toh, David W. M. Tai, Brian K. P. Goh, Jen San Wong, Kiang Hiong Tay, Anthony S. W. Goh, Sean X. Yan, Kelvin S. H. Loke, Sue Ping Thang, Apoorva Gogna, Chow Wei Too, Farah Gillian Irani, Sum Leong, Kiat Hon Lim, Choon Hua Thng; Asian Oncology Summit. Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009. Liver Cancer. 2016 March 17;5:97-106.
  19. Hee Chul Park, Jeong Il Yu, Jason Chia-Hsien Cheng, Zhao Chong Zeng, Ji Hong Hong, Michael Lian Chek Wang, Mi Sook Kim, Kwan Hwa Chi, Po-Ching Liang, Rheun-Chuan Lee, Wan-Yee Lau, Kwang Hyub Han, Pierce Kah-Hoe Chow, Jinsil Seong. Consensus Development from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014): Current Practice and Future Clinical Trials. Liver Cancer. 2016 May 3;5:162-174.
  20. Chua ML, Tan SH, Kusumawidjaja G, Shwe MT, Cheah SL, Fong KW, Soong YL, Wee JT, Tan TW. Neutrophil-to-lymphocyte ratio as a prognostic marker in locally advanced nasopharyngeal carcinoma: A pooled analysis of two randomised controlled trials. Eur J Cancer. 2016 Nov;67:119-129.
  21. Lalonde E, Alkallas R, Chua ML, et al. Translating a prognostic DNA genomic classifier into the clinic: retrospective validation in 563 localized prostate tumours. Eur Urol. 2017 Jul;72(1):22-31. doi: 10.1016/j.eururo.2016.10.013. Epub 2016 Nov 1.
  22. Fraser M, Sabelnykova V, Yamaguchi TN, Heisler LE, Livingstone J, Huang V, Shiah YJ, Yousif F, Lin XH, Masella AP, Fox N, Xie M, Prokopec SD, Berlin A, Lalonde E, Trudel D, Luo XM, Beck TA, Meng A, Zhang JY, D’Costa A, Denroche RE, Kong HY, Espiritu SM, Chua ML, et al. Genomic hallmarks of localized, non-indolent prostate cancer. Nature. 2017 Jan 19;541(7637):359-364. doi: 10.1038/nature20788. Epub 2017 Jan 9.
  23. Chua KL, Kusumawidjaja G, Murgic J, Chua ML. Adjuvant Treatment following Radical Cystectomy for Muscle-invasive Urothelial Carcinoma and Variant Histological Subtypes – Is There a Role for Radiotherapy? ESMO Open 2016;1(6):000123.
  24. Chua ML, van der Kwast TH, Bristow RG. Intraductal carcinoma of the prostate gland: Anonymous to Ominous. Eur Urol. doi: 10.1016/j.eururo.2017.04.004. [Published online April 14, 2017;
  25. Raziee H, Moraes FY, Murgic J, Chua ML, et al. Improved outcomes with dose escalation in localized prostate cancer treated with precision image-guided radiotherapy. Radiother Oncol. Radiother Oncol. 2017 Apr 20. pii: S0167-8140(17)30143-3. doi: 10.1016/j.radonc.2017.04.003. [Epub ahead of print]
  26. Chua ML, Lo W, Pintilie M, et al. A Prostate Cancer “Nimbosus”: Genomic instability and SChLAP1 dysregulation underpins aggression of intraductal and cribriform sub-pathologies. Eur Urol. 2017 May 13. pii: S0302-2838(17)30344-5. doi: 10.1016/j.eururo.2017.04.034. [Epub ahead of print]